Citadel Advisors’s Profound Medical PROF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $273K | Sell |
46,310
-26,011
| -36% | -$153K | ﹤0.01% | 4705 |
|
|
2025
Q1 | $421K | Buy |
72,321
+26,230
| +57% | +$153K | ﹤0.01% | 4145 |
|
|
2024
Q4 | $346K | Buy |
46,091
+19,146
| +71% | +$144K | ﹤0.01% | 4380 |
|
|
2024
Q3 | $214K | Buy |
+26,945
| New | +$214K | ﹤0.01% | 4573 |
|
|
2024
Q2 | – | Sell |
-10,607
| Closed | -$90.5K | – | 6609 |
|
|
2024
Q1 | $90.5K | Sell |
10,607
-9,111
| -46% | -$77.7K | ﹤0.01% | 5117 |
|
|
2023
Q4 | $167K | Buy |
19,718
+18,809
| +2,069% | +$160K | ﹤0.01% | 4690 |
|
|
2023
Q3 | $9.27K | Sell |
909
-11,285
| -93% | -$115K | ﹤0.01% | 5445 |
|
|
2023
Q2 | $159K | Buy |
+12,194
| New | +$159K | ﹤0.01% | 4552 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6404 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6560 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6508 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6717 |
|
|
2022
Q1 | – | Sell |
-33,343
| Closed | -$374K | – | 6937 |
|
|
2021
Q4 | $374K | Buy |
33,343
+6,535
| +24% | +$73.3K | ﹤0.01% | 4900 |
|
|
2021
Q3 | $392K | Sell |
26,808
-5,639
| -17% | -$82.5K | ﹤0.01% | 4773 |
|
|
2021
Q2 | $531K | Sell |
32,447
-49,466
| -60% | -$810K | ﹤0.01% | 4662 |
|
|
2021
Q1 | $1.65M | Buy |
81,913
+48,138
| +143% | +$970K | ﹤0.01% | 3384 |
|
|
2020
Q4 | $694K | Buy |
33,775
+10,692
| +46% | +$220K | ﹤0.01% | 3579 |
|
|
2020
Q3 | $407K | Buy |
+23,083
| New | +$407K | ﹤0.01% | 3650 |
|
|
2020
Q2 | – | Sell |
-19,234
| Closed | -$187K | – | 5153 |
|
|
2020
Q1 | $187K | Buy |
+19,234
| New | +$187K | ﹤0.01% | 4110 |
|